Literature DB >> 33468135

Acquired pure red cell aplasia and T cell large granular lymphocytic leukaemia in patients with autoimmune polyglandular syndrome type 1.

Jing Ruan1, Xuan Wang1, Xianyong Jiang1, Miao Chen2.   

Abstract

BACKGROUND: Pure red cell aplasia (PRCA) and large granular lymphocytic leukaemia (LGLL) are very rare complications of autoimmune polyendocrine syndrome type 1 (APS1). Here, we report a case of APS1 with PRCA and LGLL. Previous cases were reviewed, and possible mechanisms are discussed. CASE
PRESENTATION: A 31-year-old female presented with anaemia and was diagnosed with PRCA in our centre. She also had hypoparathyroidism for 24 years, premature ovarian failure for 10 years, osteoporosis for 5 years, recurrent pneumonia with bronchiectasis for 4 years and chronic diarrhoea for 1 year. Boosted whole-exome analysis showed AIRE heterozygous mutations, confirming the diagnosis as APS1. LGLL was diagnosed during follow-up. The PRCA responded well to glucocorticoid. treatment
CONCLUSION: AIRE is causally related to the development of LGLL and consequent PRCA, which may be due to some immunological mechanisms.

Entities:  

Keywords:  AIRE gene mutation; Autoimmune polyendocrine syndrome type 1; Large granular lymphocytic leukaemia; Pure red cell aplasia

Year:  2021        PMID: 33468135      PMCID: PMC7814426          DOI: 10.1186/s12920-020-00866-y

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


  21 in total

1.  Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors.

Authors:  R Handgretinger; A Geiselhart; A Moris; R Grau; O Teuffel; W Bethge; L Kanz; P Fisch
Journal:  N Engl J Med       Date:  1999-01-28       Impact factor: 91.245

2.  Human gamma delta T-cell receptor-positive cell-mediated inhibition of erythropoiesis in vitro in a patient with type I autoimmune polyglandular syndrome and pure red blood cell aplasia.

Authors:  T Hara; Y Mizuno; M Nagata; Y Okabe; S Taniguchi; M Harada; Y Niho; K Oshimi; S Ohga; Y Yoshikai
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

Review 3.  Autoimmune polyendocrine syndromes.

Authors:  Maurizio Cutolo
Journal:  Autoimmun Rev       Date:  2013-09-18       Impact factor: 9.754

Review 4.  Pure red cell aplasia.

Authors:  Robert T Means
Journal:  Blood       Date:  2016-11-24       Impact factor: 22.113

Review 5.  Autoimmune Polyendocrine Syndromes.

Authors:  Eystein S Husebye; Mark S Anderson; Olle Kämpe
Journal:  N Engl J Med       Date:  2018-03-22       Impact factor: 91.245

6.  Large granular lymphocyte leukemia with pure red cell aplasia associated with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: an unfortuitous association?

Authors:  B Hervier; M Rimbert; H Maisonneuve; M A Hamidou
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Jul-Sep       Impact factor: 3.219

Review 7.  AIRE-mutations and autoimmune disease.

Authors:  Øyvind Bruserud; Bergithe E Oftedal; Anette B Wolff; Eystein S Husebye
Journal:  Curr Opin Immunol       Date:  2016-08-06       Impact factor: 7.486

8.  Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.

Authors:  Nadine Dragin; Jacky Bismuth; Géraldine Cizeron-Clairac; Maria Grazia Biferi; Claire Berthault; Alain Serraf; Rémi Nottin; David Klatzmann; Ana Cumano; Martine Barkats; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

Review 9.  The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1).

Authors:  Can-Jie Guo; Patrick S C Leung; Weici Zhang; Xiong Ma; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2017-11-04       Impact factor: 9.754

10.  Large granular lymphocytic leukemia complicating autoimmune polyglandular syndrome type 1 in siblings.

Authors:  Jonathan S Harrison; Harsh Parmar; Xiangbing D Wang
Journal:  Clin Case Rep       Date:  2018-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.